BRITISH AND EIRE ASSOCIATION OF VITREORETINAL SURGEONS
The objectives of the CIO are the advancement of health among those with vitreoretinal (VR) diseases and related conditions.
Financial health, per its FY2025 accounts
The charity reported a net surplus of £26,140 for the year ended 30 September 2025, with total unrestricted funds increasing to £242,320. This figure exceeds the stated reserves policy target of £100,000, indicating a strong financial position. The accounts were prepared on a going concern basis with no material uncertainties identified.
What the accounts disclose
“The policy of the Charity is to seek to maintain reserves at a level of at least £100,000 to enable the prudent management of any unforeseen circumstances.” — page 4
“BEAVRS Trading Limited is a wholly owned trading subsidiary of the Charity, incorporated in the United Kingdom.” — page 5
Trustees
- Aman Chandra
- Assad Jalil
- Prof Dara Kilmartin
- Roxane Jo Hillier
- STEPHEN JOHN CHARLES
- Stephen Winder
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £39k | £13k |
| 30/09/2024 | £59k | £16k |
| 30/09/2023 | £64k | £17k |
| 30/09/2022 | £38k | £10k |
| 30/09/2021 | £13k | £9k |
Common questions
Is BRITISH AND EIRE ASSOCIATION OF VITREORETINAL SURGEONS financially healthy?
Per its FY2025 accounts: The charity reported a net surplus of £26,140 for the year ended 30 September 2025, with total unrestricted funds increasing to £242,320. This figure exceeds the stated reserves policy target of £100,000, indicating a strong financial position. The accounts were prepared on a going concern basis with no material uncertainties identified. Its FY2025 accounts were independently examined.